Piramal Pharma Morpeth facility gets 7 US FDA observations

Piramal Pharma Morpeth facility gets 7 US FDA observations

The observations relate to enhancements in practices, procedures and documentation, with the company preparing a detailed response within the stipulated timeline

Piramal Pharma Shares Fall 4% on USFDA Observations

Piramal Pharma fell nearly 4% on Tuesday, hitting a day low of Rs 202.55, after the USFDA raised observations at its UK manufacturing site. Here’s the reason. The US Food and Drug Administration inspected Piramal Pharma’s Morpeth facility in the UK between 3 and 11 September, checking whether it follows...